AXQ Capital’s Boundless Bio BOLD Stock Holding History

AXQ Capital’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$37.3K	Buy	+14,865	New	+$40.1K	﹤0.01%	981

Other funds holding BOLD

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.6B AUM 33.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

AXQ Capital's BOLD Position: Q3 2026 in Review

AXQ Capital opened a new position in Boundless Bio (BOLD) in Q3 2026: 14,865 shares worth $37.3K. The stake represents ﹤0.01% of the portfolio and ranks #981 among its holdings.

12 funds tracked by Wall St. Rank hold BOLD as of Q3 2026.

AXQ Capital held 14,865 shares of Boundless Bio worth $37.3K as of Q3 2026.
Boundless Bio was a new AXQ Capital position in Q3 2026.
Boundless Bio made up ﹤0.01% of AXQ Capital's portfolio in Q3 2026, its #981 holding.
12 funds tracked by Wall St. Rank held Boundless Bio as of Q3 2026.

Based on AXQ Capital's 13F filing for Q3 2026, filed 12 Nov 2026.